Dalla Chiesa, M., et al. “Tamoxifen Vs Tamoxifen Plus 13-Cis-Retinoic Acid Vs Tamoxifen Plus Interferon a–2a As First-Line Endocrine Treatments in Advanced Breast Cancer: Updated Results of a Phase II, Prospective, Randomised Multicentre Trial”. Acta Biomedica Atenei Parmensis, vol. 78, no. 3, Dec. 2007, pp. 204-9, https://mattioli1885journals.com/index.php/actabiomedica/article/view/1903.